Đang chuẩn bị liên kết để tải về tài liệu:
Aberrant methylation of NPY, PENK, and WIF1 as a promising marker for blood-based diagnosis of colorectal cancer

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

DNA methylation is a well-known epigenetic mechanism involved in epigenetic gene regulation. Several genes were reported hypermethylated in CRC, althought no gene marker was proven to be individually of sufficient sensitivity or specificity in routine clinical practice. |

TÀI LIỆU LIÊN QUAN

Monitoring of circulating tumor DNA and its aberrant methylation in the surveillance of surgical lung Cancer patients: Protocol for a prospective observational study

Quantitative DNA methylation analyses reveal stage dependent DNA methylation and association to clinico-pathological factors in breast tumors

DNA methylation analysis reveals distinct methylation signatures in pediatric germ cell tumors

Genome-wide methylation analysis identifies a core set of hypermethylated genes in CIMP-H colorectal cancer

High-risk oral leukoplakia is associated with aberrant promoter methylation of multiple genes

Alcohol dehydrogenase, iron containing, 1 promoter hypermethylation associated with colorectal cancer differentiation

Epigenomic analysis detects aberrant super-enhancer DNA methylation in human cancer

The identification and validation of EphA7 hypermethylation, a novel biomarker, in cervical cancer

Comprehensive analyses of imprinted differentially methylated regions reveal epigenetic and genetic characteristics in hepatoblastoma

báo cáo khoa học: "Aberrant DNA methylation of cancer-related genes in giant breast fibroadenoma: a case report"
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.